View in EDS

Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond.

Saved in:
Bibliographic Details
Title: Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond.
Authors: Ali S; Department of Pharmacology and Toxicology, and Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, Texas 77555, United States., Tian X; Department of Pharmacology and Toxicology, and Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, Texas 77555, United States., Cunningham KA; Department of Pharmacology and Toxicology, and Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, Texas 77555, United States., Zhou J; Department of Pharmacology and Toxicology, and Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, Texas 77555, United States.
Source: Journal of medicinal chemistry [J Med Chem] 2025 May 22; Vol. 68 (10), pp. 9831-9835.
Publication Type: Editorial
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1520-4804
DOI:10.1021/acs.jmedchem.5c01156